138 related articles for article (PubMed ID: 6629342)
1. Prognostic significance of a polypoid configuration in malignant melanoma.
McGovern VJ; Shaw HM; Milton GW
Histopathology; 1983 Sep; 7(5):663-72. PubMed ID: 6629342
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of ulceration of cutaneous melanoma.
Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
[TBL] [Abstract][Full Text] [Related]
3. Ulceration and prognosis in cutaneous malignant melanoma.
McGovern VJ; Shaw HM; Milton GW; McCarthy WH
Histopathology; 1982 Jul; 6(4):399-407. PubMed ID: 7118080
[TBL] [Abstract][Full Text] [Related]
4. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
Cox NH; Aitchison TC; Sirel JM; MacKie RM
Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of polypoid melanoma: a comparative study with non-polypoid melanomas.
Jasso-Sosa VY; Lino-Silva LS; Escobar-Jiménez MG; Galván-Bustillos JR; García-Ortega DY; Salcedo-Hernández RA; Zepeda-Najar C; Frías-Fernández P
Melanoma Res; 2023 Jun; 33(3):257-261. PubMed ID: 36866632
[TBL] [Abstract][Full Text] [Related]
6. Prognostic groups of patients with stage I melanoma.
Kuehnl-Petzoldt C; Wiebelt H; Berger H
Arch Dermatol; 1983 Oct; 119(10):816-9. PubMed ID: 6614950
[TBL] [Abstract][Full Text] [Related]
7. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
8. The female superiority in survival in clinical stage II cutaneous malignant melanoma.
Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
Cancer; 1982 May; 49(9):1941-4. PubMed ID: 7074591
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival.
Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
Cancer; 1980 Dec; 46(12):2731-5. PubMed ID: 7448711
[TBL] [Abstract][Full Text] [Related]
10. Prognostic histopathological factors in malignant melanoma.
Shaw HM; Balch CM; Soong SJ; Milton GW; McCarthy WH
Pathology; 1985 Apr; 17(2):271-4. PubMed ID: 4047730
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
12. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
13. Malignant melanoma in the elderly.
Cohen HJ; Cox E; Manton K; Woodbury M
J Clin Oncol; 1987 Jan; 5(1):100-6. PubMed ID: 3806154
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in head and neck melanoma. Effect of lesion location.
Wanebo HJ; Cooper PH; Young DV; Harpole DH; Kaiser DL
Cancer; 1988 Aug; 62(4):831-7. PubMed ID: 3395962
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
[TBL] [Abstract][Full Text] [Related]
16. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
17. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
[TBL] [Abstract][Full Text] [Related]
18. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
19. Prognosis in patients with thin malignant melanoma: influence of regression.
McGovern VJ; Shaw HM; Milton GW
Histopathology; 1983 Sep; 7(5):673-80. PubMed ID: 6629343
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
